A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)

Clinical trial NCT06210776 · RECRUITING

Trial details

NCT number: NCT06210776
Sponsor: Daiichi Sankyo
Status: RECRUITING
Study type: OBSERVATIONAL

HER2-positive Breast Cancer HER2-low Breast Cancer Breast Cancer Advanced Cancer

Start date: 2024-01-15
Primary completion: 2028-03-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.